Table 1.
Methodological quality of studies included in meta-analysis.
| Author | Year | Treatment(cases) | Study design | Quality evaluation Score* | |
|---|---|---|---|---|---|
| HAIC | TACE | ||||
| Chao An | 2021 | 92 | 68 | Nonrandomized controlled trials | 5* |
| Hee Yeon Kim | 2010 | 36 | 31 | Nonrandomized controlled trials | 6* |
| Jungang Hu | 2020 | 22 | 24 | Nonrandomized controlled trials | 6* |
| Min-Ke He | 2017 | 38 | 41 | Nonrandomized controlled trials | 6* |
| Qi-jiong Li | 2021 | 159 | 156 | Randomized controlled trials | 3† |
| Wei-Lun Tsai | 2020 | 38 | 41 | Nonrandomized controlled trials | 5* |
*
According to the Newcastle–Ottawa Scale for assessing the quality of nonrandomised studies, >=5* is divided into meta-analyses.
†
According to the quality of randomized controlled clinical trial evaluation criteria (Jadad rating scale) score> = 3 is divided into high-quality research.